DermTech, Inc.

OTCPK:DMTK.Q 주식 보고서

시가총액: US$3.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

DermTech 관리

관리 기준 확인 1/4

DermTech's CEO는 Bret Christensen, May2023 에 임명되었습니다 의 임기는 1.08 년입니다. 총 연간 보상은 $ 1.93M, 20.2% 로 구성됩니다. 20.2% 급여 및 79.8% 보너스(회사 주식 및 옵션 포함). 는 $ 363.73 가치에 해당하는 회사 주식의 0.007% 직접 소유합니다. 363.73. 경영진과 이사회의 평균 재임 기간은 각각 1.9 년과 2.7 년입니다.

주요 정보

Bret Christensen

최고 경영자

US$1.9m

총 보상

CEO 급여 비율20.2%
CEO 임기1.2yrs
CEO 소유권0.007%
경영진 평균 재임 기간2.5yrs
이사회 평균 재임 기간2.8yrs

최근 관리 업데이트

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

CEO 보상 분석

Bret Christensen 의 보수는 DermTech 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$90m

Dec 31 2023US$2mUS$389k

-US$101m

보상 대 시장: Bret 의 총 보상 ($USD 1.93M )은 US 시장( $USD 683.56K ).

보상과 수익: Bret 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Bret Christensen (53 yo)

1.2yrs

테뉴어

US$1,928,967

보상

Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...


리더십 팀

이름위치테뉴어보상소유권
Bret Christensen
President1.2yrsUS$1.93m0.0072%
$ 225.0
Kevin Sun
CFO, Treasurer & Secretary4.8yrsUS$934.85k0.57%
$ 17.9k
Ray Akhavan
General Counsel3.5yrsUS$818.76k0.19%
$ 6.0k
Steve Kunszabo
Senior Director of Investor Relationsno data데이터 없음데이터 없음
Jennifer Eilemberg
Chief Compliance Officer2yrs데이터 없음데이터 없음
Loren Clarke
Chief Medical Officer3.1yrs데이터 없음데이터 없음
Mark Aguillard
Chief Commercial Officerless than a year데이터 없음데이터 없음

2.5yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: DMTK 의 관리팀은 경험 ( 2.5 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Bret Christensen
President1.2yrsUS$1.93m0.0072%
$ 225.0
Herman Rosenman
Independent Director4.9yrsUS$149.64k0.28%
$ 8.9k
Kirk Malloy
Independent Director2yrsUS$136.64k0.095%
$ 3.0k
Matthew Posard
Independent Chairman of the Board8yrsUS$188.64k0.35%
$ 11.0k
Mark Capone
Independent Director2yrsUS$139.64k0.082%
$ 2.6k
Cynthia Collins
Independent Director4.9yrsUS$156.64k0.20%
$ 6.2k
Nathalie Keraudy
Independent Director2.8yrsUS$134.64k0.093%
$ 2.9k

2.8yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: DMTK 의 이사회경험(평균 재직 기간 2.7 년)으로 간주되지 않으므로 새 이사회가 필요합니다.